CP and COVID-19: On 24 March 2020, the Food and Drug Administration, USA (FDA) issued guidelines for CP donation and application of CP in COVID-19 patients under the emergency investigational new drug (IND) applications, and the IND regulatory pathway (21 CFR 312).